Abstract:Background: An estimated 185,000 patients per year undergo an extremity amputation in the United States (over 500 amputations/day). Prolonged postoperative opioid use, defined as the presence of a filled opioid prescription between 90 and 180 days following the operative amputation procedure, affects nearly 50% of amputees. Moreover, the use of preoperative benzodiazepines, muscle relaxants, anticonvulsants, and antidepressants is strongly linked to prolonged opioid use suggesting new therapeutic strategies are needed. The goal of this study was to better understand how well post-amputation pain is currently treated by selected pharmacologic agents and the success rates of these existing agents. Methods: The available literature on PubMed was screened for articles that used randomized-controlled trial (RCT) study designs and gabapentinoids (eg, gabapentin or pregabalin) or opioids (eg, morphine). Two morphine-related RCTs using at least 50% pain reduction responder criteria were combined and qualitatively compared with two gabapentin trials that were previously combined to understand the potential benefits of these drugs in post-amputation pain management compared with placebo. Results: All 4 trials included measured post-amputation pain over a 4- to 6-week acute period. The combined opioid analysis demonstrated a treatment effect that favored morphine (P=0.02) over placebo and indicated the number needed to treat (NNT) of 3.9 (95% CI: 2.5, 9.3) patients. Similarly, the previously combined analysis of gabapentin trials favored gabapentin over placebo and indicated an estimated NNT of 8.9 (95% CI: 5.3, 27.8). Conclusion: Patients undergoing limb amputation have a clear unmet need for more adequate chronic pain control. Given that post-amputation pain is often diagnosed as a chronic condition, persisting for at least 90 days, our data highlight the need for larger sample sizes and longer-term controlled trials to better understand the advantages and disadvantages of chronic use of gabapentinoids and opioids/opioid combination drugs in this patient population.

Postamputation Pain Management

Phantom Limb Pain Management

Approaches to neuropathic amputation-related pain: narrative review of surgical, interventional, and medical treatments

Chronic post amputation pain: pathophysiology and prevention options for a heterogenous phenomenon

Integrating Complementary Therapies in Managing Phantom Limb Pain: A Case Review

Post-Amputation Pain: Combined Analyses of Randomized Controlled Trials Evaluating Opioids and Gabapentinoids versus Placebo

Current and future options for the management of phantom-limb pain

New modalities of pain treatment after outpatient orthopaedic surgery

Treating Intractable Postamputation Pain with Noninvasive, Wearable, Nonthermal, Pulsed Shortwave (Radiofrequency) Therapy: A 12-Patient Case Series

Post-mastectomy Pain Syndrome: A Review Article and Emerging Treatment Modalities

Botulinum toxin therapy for management of phantom and residual limb pain following amputation: A systematic review

[A multimodal and multidisciplinary postoperative pain management concept]

The mechanisms and management of persistent postsurgical pain

A Review on the Management of Peripheral Neuropathic Pain Following Breast Cancer

Insights into optimizing phantom pain management: A human‐centered approach to end‐user perspectives

Neuromodulation for Adjunctive Treatment in Postmastectomy Pain Syndrome

Pharmacologic Management of Persistent Pain in Cancer Survivors

Multimodal pain management after total joint arthroplasty

Postoperative pain management in the postanesthesia care unit: an update

Sciatic-nerve radiofrequency ablation for phantom limb pain: A case report

SCIENTIFIC UPDATE ON POST-OPERATIVE PAIN MANAGEMENT IN ORTHOPEDIC SURGERY